We observed that RBMS3−/nuclear HIF1A+ group showed poorer differentiation than RBMS3+/nuclear HIF1A− group in GC samples, which further supported that RBMS3−/nuclear HIF1A+ GC tumors were more malignant than RBMS3+/nuclear HIF1A− tumors. This evidence concerns the gene HIF1A and gastric cancer.